US Codex
C.F.R.
Browse by date
Notes

42 C.F.R. §§ 493.1281–493.1299

7 sections in range

§493.1281. Standard: Comparison of test results.

42 C.F.R. § 493.1281

(a)
If a laboratory performs the same test using different methodologies or instruments, or performs the same test at multiple testing sites, the laboratory must have a system that twice a year evaluates and defines the relationship between test results using the different methodologies, instruments, or testing sites.
(b)
The laboratory must have a system to identify and assess patient test results that appear inconsistent with the following relevant criteria, when available:
(1)
Patient age.
(2)
Sex.
(3)
Diagnosis or pertinent clinical data.
(4)
Distribution of patient test results.
(5)
Relationship with other test parameters.
(c)
The laboratory must document all test result comparison activities.
Notes, amendments, and revision history

Source

Source: 68 FR 3703, Jan. 24, 2003, unless otherwise noted.

Authority

Authority: 42 U.S.C. 263a, 1302, 1395x(e), 1395x(s)(3) and (s)(17).

Source

Source: 55 FR 9576, Mar. 14, 1990, unless otherwise noted.

§493.1282. Standard: Corrective actions.

42 C.F.R. § 493.1282

(a)
Corrective action policies and procedures must be available and followed as necessary to maintain the laboratory's operation for testing patient specimens in a manner that ensures accurate and reliable patient test results and reports.
(b)
The laboratory must document all corrective actions taken, including actions taken when any of the following occur:
(1)
Test systems do not meet the laboratory's verified or established performance specifications, as determined in § 493.1253(b), which include but are not limited to—
(i)
Equipment or methodologies that perform outside of established operating parameters or performance specifications;
(ii)
Patient test values that are outside of the laboratory's reportable range of test results for the test system; and
(iii)
When the laboratory determines that the reference intervals (normal values) for a test procedure are inappropriate for the laboratory's patient population.
(2)
Results of control or calibration materials, or both, fail to meet the laboratory's established criteria for acceptability. All patient test results obtained in the unacceptable test run and since the last acceptable test run must be evaluated to determine if patient test results have been adversely affected. The laboratory must take the corrective action necessary to ensure the reporting of accurate and reliable patient test results.
(3)
The criteria for proper storage of reagents and specimens, as specified under § 493.1252(b), are not met.
Notes, amendments, and revision history

Source

Source: 68 FR 3703, Jan. 24, 2003, unless otherwise noted.

Authority

Authority: 42 U.S.C. 263a, 1302, 1395x(e), 1395x(s)(3) and (s)(17).

Source

Source: 55 FR 9576, Mar. 14, 1990, unless otherwise noted.

§493.1283. Standard: Test records.

42 C.F.R. § 493.1283

(a)
The laboratory must maintain an information or record system that includes the following:
(1)
The positive identification of the specimen.
(2)
The date and time of specimen receipt into the laboratory.
(3)
The condition and disposition of specimens that do not meet the laboratory's criteria for specimen acceptability.
(4)
The records and dates of all specimen testing, including the identity of the personnel who performed the test(s).
(b)
Records of patient testing including, if applicable, instrument printouts, must be retained.
Notes, amendments, and revision history

Source

Source: 68 FR 3703, Jan. 24, 2003, unless otherwise noted.

Authority

Authority: 42 U.S.C. 263a, 1302, 1395x(e), 1395x(s)(3) and (s)(17).

Source

Source: 55 FR 9576, Mar. 14, 1990, unless otherwise noted.

§493.1289. Standard: Analytic systems quality assessment.

42 C.F.R. § 493.1289

(a)
The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and when indicated, correct problems identified in the analytic systems specified in §§ 493.1251 through 493.1283.
(b)
The analytic systems quality assessment must include a review of the effectiveness of corrective actions taken to resolve problems, revision of policies and procedures necessary to prevent recurrence of problems, and discussion of analytic systems quality assessment reviews with appropriate staff.
(c)
The laboratory must document all analytic systems quality assessment activities.
Notes, amendments, and revision history

Amendments

[68 FR 3703, Jan. 24, 2003; 68 FR 50724, Aug. 22, 2003]

Source

Source: 68 FR 3703, Jan. 24, 2003, unless otherwise noted.

Authority

Authority: 42 U.S.C. 263a, 1302, 1395x(e), 1395x(s)(3) and (s)(17).

Source

Source: 55 FR 9576, Mar. 14, 1990, unless otherwise noted.

Amendments

[68 FR 3703, Jan. 24, 2003; 68 FR 50724, Aug. 22, 2003]

§493.1290. Condition: Postanalytic systems.

42 C.F.R. § 493.1290

Each laboratory that performs nonwaived testing must meet the applicable postanalytic systems requirements in § 493.1291 unless HHS approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7) that provides equivalent quality testing. The laboratory must monitor and evaluate the overall quality of the postanalytic systems and correct identified problems as specified in § 493.1299 for each specialty and subspecialty of testing performed.
Notes, amendments, and revision history

Source

Source: 68 FR 3703, Jan. 24, 2003, unless otherwise noted.

Authority

Authority: 42 U.S.C. 263a, 1302, 1395x(e), 1395x(s)(3) and (s)(17).

Source

Source: 55 FR 9576, Mar. 14, 1990, unless otherwise noted.

§493.1291. Standard: Test report.

42 C.F.R. § 493.1291

(a)
The laboratory must have an adequate manual or electronic system(s) in place to ensure test results and other patient-specific data are accurately and reliably sent from the point of data entry (whether interfaced or entered manually) to final report destination, in a timely manner. This includes the following:
(1)
Results reported from calculated data.
(2)
Results and patient-specific data electronically reported to network or interfaced systems.
(3)
Manually transcribed or electronically transmitted results and patient-specific information reported directly or upon receipt from outside referral laboratories, satellite or point-of-care testing locations.
(b)
Test report information maintained as part of the patient's chart or medical record must be readily available to the laboratory and to CMS or a CMS agent upon request.
(c)
The test report must indicate the following:
(1)
For positive patient identification, either the patient's name and identification number, or a unique patient identifier and identification number.
(2)
The name and address of the laboratory location where the test was performed.
(3)
The test report date.
(4)
The test performed.
(5)
Specimen source, when appropriate.
(6)
The test result and, if applicable, the units of measurement or interpretation, or both.
(7)
Any information regarding the condition and disposition of specimens that do not meet the laboratory's criteria for acceptability.
(d)
Pertinent “reference intervals” or “normal” values, as determined by the laboratory performing the tests, must be available to the authorized person who ordered the tests and, if applicable, the individual responsible for using the test results.
(e)
The laboratory must, upon request, make available to clients a list of test methods employed by the laboratory and, as applicable, the performance specifications established or verified as specified in § 493.1253. In addition, information that may affect the interpretation of test results, for example test interferences, must be provided upon request. Pertinent updates on testing information must be provided to clients whenever changes occur that affect the test results or interpretation of test results.
(f)
Except as provided in § 493.1291(l), test results must be released only to authorized persons and, if applicable, the persons responsible for using the test results and the laboratory that initially requested the test.
(g)
The laboratory must immediately alert the individual or entity requesting the test and, if applicable, the individual responsible for using the test results when any test result indicates an imminently life-threatening condition, or panic or alert values.
(h)
When the laboratory cannot report patient test results within its established time frames, the laboratory must determine, based on the urgency of the patient test(s) requested, the need to notify the appropriate individual(s) of the delayed testing.
(i)
If a laboratory refers patient specimens for testing—
(1)
The referring laboratory must not revise results or information directly related to the interpretation of results provided by the testing laboratory;
(2)
The referring laboratory may permit each testing laboratory to send the test result directly to the authorized person who initially requested the test. The referring laboratory must retain or be able to produce an exact duplicate of each testing laboratory's report; and
(3)
The authorized person who orders a test must be notified by the referring laboratory of the name and address of each laboratory location where the test was performed.
(j)
All test reports or records of the information on the test reports must be maintained by the laboratory in a manner that permits ready identification and timely accessibility.
(k)
When errors in the reported patient test results are detected, the laboratory must do the following:
(1)
Promptly notify the authorized person ordering the test and, if applicable, the individual using the test results of reporting errors.
(2)
Issue corrected reports promptly to the authorized person ordering the test and, if applicable, the individual using the test results.
(3)
Maintain duplicates of the original report, as well as the corrected report.
(l)
Upon request by a patient (or the patient's personal representative), the laboratory may provide patients, their personal representatives, and those persons specified under 45 CFR 164.524(c)(3)(ii), as applicable, with access to completed test reports that, using the laboratory's authentication process, can be identified as belonging to that patient.
Notes, amendments, and revision history

Amendments

[68 FR 3703, Jan. 24, 2003; 68 FR 50724, Aug. 22, 2003, as amended at 79 FR 7316, Feb. 6, 2014]

Source

Source: 68 FR 3703, Jan. 24, 2003, unless otherwise noted.

Authority

Authority: 42 U.S.C. 263a, 1302, 1395x(e), 1395x(s)(3) and (s)(17).

Source

Source: 55 FR 9576, Mar. 14, 1990, unless otherwise noted.

Amendments

[68 FR 3703, Jan. 24, 2003; 68 FR 50724, Aug. 22, 2003, as amended at 79 FR 7316, Feb. 6, 2014]

§493.1299. Standard: Postanalytic systems quality assessment.

42 C.F.R. § 493.1299

(a)
The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess and, when indicated, correct problems identified in the postanalytic systems specified in § 493.1291.
(b)
The postanalytic systems quality assessment must include a review of the effectiveness of corrective actions taken to resolve problems, revision of policies and procedures necessary to prevent recurrence of problems, and discussion of postanalytic systems quality assessment reviews with appropriate staff.
(c)
The laboratory must document all postanalytic systems quality assessment activities.
Notes, amendments, and revision history

Amendments

[68 FR 3703, Jan. 24, 2003; 68 FR 50724, Aug. 22, 2003]

Source

Source: 68 FR 3703, Jan. 24, 2003, unless otherwise noted.

Authority

Authority: 42 U.S.C. 263a, 1302, 1395x(e), 1395x(s)(3) and (s)(17).

Source

Source: 55 FR 9576, Mar. 14, 1990, unless otherwise noted.

Amendments

[68 FR 3703, Jan. 24, 2003; 68 FR 50724, Aug. 22, 2003]